supplies too.
The latest warning follows a shortage of 1.25mg ramipril capsules reported earlier this year.
A serious shortage protocol remains in place for the capsules, meaning that pharmacists can at times restrict supplies to one month’s worth.
The protocol also allows pharmacists to provide a reduced quantity compared with the number of days originally prescribed.
Pharmacy leaders have raised concerns about thecontinuing shortage.
Four recalls of ramipril products were issued by the Medicines and Healthcare products Regulatory Agency between February and May this year as precautionary measures.
Olivier Picard, chair of the National Pharmacy Association, warned that supplies of
Comments